Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HBV Infection (HBeAg Negative)”

96 trials

Showing 20 of 96 results

Post-approval studies (Phase 4)Study completedNCT00338780
What this trial is testing

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong
Testing effectiveness (Phase 2)Ended earlyNCT03780543
What this trial is testing

ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 92
Testing effectiveness (Phase 2)UnknownNCT01027065
What this trial is testing

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients

Who this might be right for
Chronic Hepatitis B
Cytheris SA 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT06900166
What this trial is testing

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 360
Very early researchWithdrawnNCT05550519
What this trial is testing

A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment

Who this might be right for
Hepatitis B, Chronic
Janssen Pharmaceutica N.V., Belgium
Not applicableWithdrawnNCT01260610
What this trial is testing

Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India
Post-approval studies (Phase 4)UnknownNCT02838810
What this trial is testing

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT02881008
What this trial is testing

Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hepatera Ltd. 48
Large-scale testing (Phase 3)Study completedNCT00114361
What this trial is testing

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Foundation for Liver Research 138
Not applicableUnknownNCT03123653
What this trial is testing

To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.

Who this might be right for
Hepatitis B
Institute of Liver and Biliary Sciences, India 118
Testing effectiveness (Phase 2)UnknownNCT04568265
What this trial is testing

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hep BHBV
Ascentage Pharma Group Inc. 122
Not applicableUnknownNCT05490836
What this trial is testing

Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00442572
What this trial is testing

SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 21
Post-approval studies (Phase 4)Study completedNCT01277601
What this trial is testing

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 751
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Post-approval studies (Phase 4)Study completedNCT02594293
What this trial is testing

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 180
Large-scale testing (Phase 3)Study completedNCT01095835
What this trial is testing

Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 131
Not applicableStudy completedNCT01734018
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Looking for participantsNCT07370207
What this trial is testing

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Who this might be right for
Hepatitis B, Chronic
AusperBio Therapeutics Inc. 84
Testing effectiveness (Phase 2)Looking for participantsNCT07069569
What this trial is testing

Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation